Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 10, 2019 Off

New post-hoc analysis shows consistent cardiorenal risk reductions of empagliflozin in a sub-group of adults with type 2 diabetes and chronic kidney disease without overt proteinuria

By BusinessWire

Findings from a post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and chronic kidney disease…

June 10, 2019 Off

China Pharmaceutical Distribution Industry Report, 2019-2025 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Distribution Industry Report, 2019-2025” report has been added to ResearchAndMarkets.com’s offering. China’s pharmaceutical distribution industry has…

June 10, 2019 Off

China Pharmaceutical Distribution Industry Report, 2019-2025 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Distribution Industry Report, 2019-2025” report has been added to ResearchAndMarkets.com’s offering. China’s pharmaceutical distribution industry has…

June 10, 2019 Off

Seattle Genetics’ Antibody-Drug Conjugate Technology Utilized in Genentech’s Polivy, Now Approved by FDA

By BusinessWire

-Approval Triggers Milestone Payment and Royalties on Worldwide Net Sales- BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced U.S. Food…

June 10, 2019 Off

Seattle Genetics’ Antibody-Drug Conjugate Technology Utilized in Genentech’s Polivy, Now Approved by FDA

By BusinessWire

-Approval Triggers Milestone Payment and Royalties on Worldwide Net Sales- BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced U.S. Food…

June 10, 2019 Off

FDA Grants Genentech’s Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma

By BusinessWire

– New targeted medicine shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared…

June 10, 2019 Off

FDA Grants Genentech’s Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma

By BusinessWire

– New targeted medicine shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared…

June 10, 2019 Off

BioCelerate Launches Two New Initiatives and Expands Membership

By BusinessWire

Establishes Working Group with the FDA on Nonclinical Initiatives PHILADELPHIA–(BUSINESS WIRE)–BioCelerate, a subsidiary of TransCelerate BioPharma Inc., today announced a…

June 10, 2019 Off

Fresenius Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist® Prefilled Syringe in 3 mg per 3 mL Presentation

By BusinessWire

Common concentration now available exclusively in FDA-approved ready-to-administer prefilled syringe LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today the immediate availability…

June 10, 2019 Off

Cell Based Assay & High Content Screening Markets – Customized Forecasting and Analysis 2019-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cell Based Assay & High Content Screening Markets – Market Forecasts by Application With Executive and Consultant Guides…

Posts pagination

Previous 1 … 3,112 3,113 3,114 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine